Merck, Eisai sign deal to further develop, sell Eisai cancer drug

(Reuters) - Merck & Co and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai's cancer drug Lenvima, which is already approved in many countries for two uses.

from Reuters: Health News http://ift.tt/2G1zwZv